951
Views
10
CrossRef citations to date
0
Altmetric
Research Paper

Overexpressed microRNA-494 represses RIPK1 to attenuate hippocampal neuron injury in epilepsy rats by inactivating the NF-κB signaling pathway

, , , , , , & show all
Pages 1298-1313 | Received 30 Oct 2019, Accepted 06 Mar 2020, Published online: 19 Apr 2020

References

  • Ding X, Zheng Y, Guo Y, et al. Active epilepsy prevalence, the treatment gap, and treatment gap risk profile in eastern China: A population-based study. Epilepsy Behav. 2018;78:20–24.
  • Rakers F, Walther M, Schiffner R, et al. Weather as a risk factor for epileptic seizures: A case-crossover study. Epilepsia. 2017;58(7):1287–1295. .
  • Yuping W, Yicong L. Brain stimulation for epilepsy. Chin Med J (Engl). 2014;127(18):3201–3203.
  • Meyer A-C, Dua T, Ma J, et al. Global disparities in the epilepsy treatment gap: a systematic review. Bull World Health Organ. 2010;88(4):260–266.
  • Kunz M, Göttlich C, Walles T, et al. MicroRNA-21 versus microRNA-34: lung cancer promoting and inhibitory microRNAs analysed in silico and in vitro and their clinical impact. Tumour Biol. 2017;39(7):1010428317706430.
  • Xia L, Li D, Lin C, et al. Comparative study of joint bioinformatics analysis of underlying potential of ‘neurimmiR’, miR-212-3P/miR-132-3P, being involved in epilepsy and its emerging role in human cancer. Oncotarget. 2017;8(25):40668–40682.
  • Zheng H, Chen L, Zhang S. Involvement of upregulation of miR-210 in a rat epilepsy model. Neuropsychiatr Dis Treat. 2016;12:1731–1737.
  • Rubinsztein, David C. RIPK1 promotes inflammation and β-amyloid accumulation in Alzheimer’s disease. Oncol Lett. 2017;114(41):4245–4251.
  • Li Y, Huang C, Feng P, et al. Aberrant expression of miR-153 is associated with overexpression of hypoxia-inducible factor-1α in refractory epilepsy. Sci Rep. 2016;6:32091.
  • Ou-Yang Q, He X, Yang A, et al. Interference with NTSR1 expression exerts an anti-invasion effect via the Jun/miR-494/SOCS6 axis of glioblastoma cells. Cell Physiol Biochem. 2018;49(6):2382–2395.
  • Xu XH, Zhang SJ, Hu QB, et al. Effects of microRNA-494 on proliferation, migration, invasion, and apoptosis of medulloblastoma cells by mediating c-myc through the p38 MAPK signaling pathway. J Cell Biochem. 2018;120(11). doi:10.1002/jcb.27559.
  • Polykratis A, Hermance N, Zelic M, et al. Cutting edge: RIPK1 Kinase inactive mice are viable and protected from TNF-induced necroptosis in vivo. J Immunol. 2014;193(4):1539–1543.
  • Moerke C, Jaco I, Dewitz C, et al. The anticonvulsive Phenhydan® suppresses extrinsic cell death. Cell Death Differ. 2019;26(9):1631–1645.
  • Melo-Lima S, Celeste Lopes M, Mollinedo F. Necroptosis is associated with low procaspase-8 and active RIPK1 and −3 in human glioma cells. Oncoscience. 2014;1(10):649–664.
  • Rubinsztein DC. RIPK1 promotes inflammation and β-amyloid accumulation in Alzheimer’s disease. Proc Natl Acad Sci U S A. 2017;114(41):10813–10814.
  • Han LP, Li C-J, Sun B, et al. Protective effects of celastrol on diabetic liver injury via TLR4/MyD88/NF-kappaB signaling pathway in type 2 diabetic rats. J Diabetes Res. 2016;2016:2641248.
  • Jiang Y, Zhou J, Luo P, et al. Prosaposin promotes the proliferation and tumorigenesis of glioma through toll-like receptor 4 (TLR4)-mediated NF-κB signaling pathway. EBioMedicine. 2018;37:78–90.
  • Jing H, Wang S, Wang M, et al. Isobavachalcone attenuates MPTP-induced Parkinson’s disease in mice by inhibition of microglial activation through nf-κb pathway. PLoS One. 2017;12(1):e0169560.
  • Qu Z, Jia L, Xie T, et al. (–)-Epigallocatechin-3-gallate protects against lithium-pilocarpine-induced epilepsy by inhibiting the toll-like receptor 4 (TLR4)/nuclear Factor-κB (NF-κB) Signaling Pathway. Med Sci Monit. 2019;25:1749–1758.
  • Tang Z-P, Zhao W, Du J-K, et al. miR-494 contributes to estrogen protection of cardiomyocytes against oxidative stress via targeting (NF-κB) repressing factor. Front Endocrinol (Lausanne). 2018;9:215.
  • Zeng X, Hu K, Chen L, et al. The effects of ginsenoside compound K against epilepsy by enhancing the γ-aminobutyric acid signaling pathway. Front Pharmacol. 2018;9:1020.
  • Inoue O, Sugiyama E, Hasebe N, et al. Methyl ethyl ketone blocks status epilepticus induced by lithium-pilocarpine in rats. Br J Pharmacol. 2009;158(3):872–878.
  • Yuan J, Huang H, Zhou X, et al. MicroRNA-132 interact with p250GAP/Cdc42 pathway in the hippocampal neuronal culture model of acquired epilepsy and associated with epileptogenesis process. Neural Plast. 2016;2016:5108489.
  • Ayuk SM, Abrahamse H, Houreld NN. The role of photobiomodulation on gene expression of cell adhesion molecules in diabetic wounded fibroblasts in vitro. J Photochem Photobiol B. 2016;161:368–374.
  • Bashir MBA, Cumber SN. The quality of life and inequalities in health services for epilepsy treatment among patience in the urban cities of Sudan. Pan Afr Med J. 2019;33:10.
  • Feliciano A, Garcia-Mayea Y, Jubierre L, et al. miR-99a reveals two novel oncogenic proteins E2F2 and EMR2 and represses stemness in lung cancer. Cell Death Dis. 2017;8(10):e3141.
  • Cheng L, Kong B, Zhao Y, et al. miR-494 inhibits cervical cancer cell proliferation through upregulation of SOCS6 expression. Oncol Lett. 2018;15(3):3075–3080.
  • Ofengeim D, Mazzitelli S, Ito Y, et al. RIPK1 mediates a disease-associated microglial response in Alzheimer’s disease. Proc Natl Acad Sci U S A. 2017;114(41):E8788–E8797.
  • Yao C, Li G, Cai M, et al. Expression and genetic polymorphism of necroptosis related protein RIPK1 is correlated with severe hepatic ischemia-reperfusion injury and prognosis after hepatectomy in hepatocellular carcinoma patients. Cancer Biomarkers. 2017;20(1):23–29.
  • Wu P, Kong L, Li J. MicroRNA-494-3p protects rat cardiomyocytes against septic shock via PTEN. Exp Ther Med. 2019;17(3):1706–1716.
  • Zhao C, Jiang J, Wang Y-L, et al. Overexpression of microRNA-590-3p promotes the proliferation of and inhibits the apoptosis of myocardial cells through inhibition of the NF-κB signaling pathway by binding to RIPK1. J Cell Biochem. 2019;120(3):3559–3573.
  • Geng W, Liu L. MiR-494 alleviates lipopolysaccharide (LPS)-induced autophagy and apoptosis in PC-12 cells by targeting IL-13. Adv Clin Exp Med. 2018;28(1):85–94.
  • He Y, Bai J, Liu P, et al. miR-494 protects pancreatic β-cell function by targeting PTEN in gestational diabetes mellitus. Excli J. 2017;16:1297–1307.
  • Qiu X, Zhuang M, Lu Z, et al. RIPK1 suppresses apoptosis mediated by TNF and caspase-3 in intervertebral discs. J Transl Med. 2019;17(1):135.
  • Wang X, Zhang X, Ren X-P, et al. MicroRNA-494 targeting both proapoptotic and antiapoptotic proteins protects against ischemia/reperfusion-induced cardiac injury. Circulation. 2010;122(13):1308–1318.
  • Tan H, Qi J, Fan B-Y, et al. MicroRNA-24-3p attenuates myocardial ischemia/reperfusion injury by suppressing RIPK1 expression in mice. Cell Physiol Biochem. 2018;51(1):46–62.
  • O’Donnell MA, Ting AT. NFκB and ubiquitination: partners in disarming RIPK1-mediated cell death. Immunol Res. 2012;54(1–3):214–226.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.